Datasets:

electricsheepafrica
/

postmarket-surveillance-pharmacovigilance

id int64	pv_level string	reporting_facility_id string	reporter_type string	facility_type string	patient_age_group string	patient_sex string	suspect_medicine_class string	suspect_medicine_registered int64	suspect_medicine_WHO_PQ int64	sf_medicine_suspected int64	sf_confirmed int64	adverse_event_type string	seriousness string	causality_assessment string	ICSR_completeness_score int64	report_within_30_days int64	follow_up_obtained int64	entered_in_vigibase int64	outcome string	estimated_underreporting_factor int64	year int64
1	emerging	PV_0027	nurse	community	adult	male	corticosteroid	0	0	1	0	GI_disturbance	serious_life_threatening	not_assessed	56	0	0	0	recovered	25	2,024
2	emerging	PV_0232	patient	community	adult	female	vaccine	1	0	1	0	hypoglycaemia	serious_hospitalisation	not_assessed	32	0	0	1	recovered	25	2,023
3	emerging	PV_0099	patient	health_centre	elderly	female	vaccine	0	0	0	0	hypoglycaemia	non_serious	certain	44	0	0	0	recovering	25	2,023
4	emerging	PV_0068	physician	tertiary_hospital	adult	female	anticonvulsant	1	0	0	0	GI_disturbance	non_serious	not_assessed	52	0	0	0	recovered	25	2,022
5	emerging	PV_0275	patient	health_centre	adult	female	vaccine	1	1	1	0	haematological_toxicity	non_serious	not_assessed	47	0	0	0	recovered	25	2,023
6	emerging	PV_0088	nurse	tertiary_hospital	child	female	antidiabetic	1	0	0	0	injection_site_reaction	non_serious	not_assessed	25	0	0	0	recovered	25	2,023
7	emerging	PV_0164	CHW	community	adult	male	antihypertensive	1	0	1	0	hepatotoxicity	non_serious	not_assessed	45	1	0	1	unknown	25	2,023
8	emerging	PV_0053	pharmacist	health_centre	neonate	female	vaccine	1	0	0	0	teratogenicity	non_serious	not_assessed	44	0	0	0	recovered	25	2,024
9	emerging	PV_0003	physician	health_centre	child	female	antidiabetic	0	0	1	0	anaphylaxis	non_serious	not_assessed	71	0	0	0	unknown	25	2,022
10	emerging	PV_0268	nurse	district_hospital	elderly	male	antimalarial	1	0	0	0	injection_site_reaction	serious_disability	not_assessed	44	0	0	0	recovering	25	2,020
11	emerging	PV_0221	pharmacist	pharmacy	adolescent	male	vaccine	1	0	0	0	teratogenicity	non_serious	not_assessed	49	0	0	1	recovered	25	2,021
12	emerging	PV_0224	physician	private_clinic	child	female	antihypertensive	1	0	0	0	injection_site_reaction	non_serious	unclassifiable	32	0	0	0	unknown	25	2,022
13	emerging	PV_0288	physician	health_centre	adult	male	antibiotic	1	0	0	0	teratogenicity	serious_hospitalisation	not_assessed	31	1	1	0	unknown	25	2,021
14	emerging	PV_0277	nurse	private_clinic	elderly	female	ARV	1	0	0	0	GI_disturbance	non_serious	unlikely	67	1	1	0	recovered	25	2,024
15	emerging	PV_0096	physician	pharmacy	child	male	antibiotic	1	1	1	0	hepatotoxicity	non_serious	not_assessed	42	0	0	0	unknown	25	2,020
16	emerging	PV_0093	physician	district_hospital	adolescent	female	antimalarial	1	0	1	0	hepatotoxicity	serious_life_threatening	unlikely	46	0	0	0	not_recovered	25	2,024
17	emerging	PV_0221	nurse	health_centre	elderly	female	antihypertensive	1	1	0	0	GI_disturbance	non_serious	not_assessed	52	0	0	0	recovered	25	2,024
18	emerging	PV_0041	other	health_centre	adult	female	antidiabetic	0	0	0	0	GI_disturbance	serious_hospitalisation	possible	37	0	1	0	recovered	25	2,024
19	emerging	PV_0217	other	community	adult	female	antifungal	1	0	1	0	skin_reaction_SJS	non_serious	not_assessed	5	0	0	0	recovering	25	2,023
20	emerging	PV_0042	other	tertiary_hospital	child	male	antidiabetic	1	0	0	0	GI_disturbance	serious_life_threatening	not_assessed	44	0	0	1	recovered	25	2,024
21	emerging	PV_0166	nurse	private_clinic	adult	female	NSAID_analgesic	1	0	0	0	teratogenicity	non_serious	not_assessed	36	1	0	0	recovered	25	2,023
22	emerging	PV_0131	CHW	district_hospital	adult	male	ARV	0	0	1	0	teratogenicity	non_serious	not_assessed	50	0	0	0	recovered	25	2,024
23	emerging	PV_0259	pharmacist	tertiary_hospital	adult	male	antifungal	0	1	1	1	lactic_acidosis	serious_hospitalisation	unlikely	29	0	0	0	not_recovered	25	2,024
24	emerging	PV_0009	physician	district_hospital	child	female	antihypertensive	0	0	0	0	skin_reaction_SJS	non_serious	not_assessed	65	0	1	0	recovered	25	2,024
25	emerging	PV_0138	physician	tertiary_hospital	adolescent	female	vaccine	1	0	1	0	GI_disturbance	non_serious	not_assessed	35	0	1	0	recovering	25	2,023
26	emerging	PV_0213	physician	tertiary_hospital	adult	male	anti_TB	1	0	0	0	GI_disturbance	non_serious	not_assessed	23	1	0	0	recovered	25	2,023
27	emerging	PV_0105	patient	private_clinic	adult	male	vaccine	1	0	0	0	GI_disturbance	non_serious	not_assessed	41	0	0	0	unknown	25	2,022
28	emerging	PV_0170	CHW	health_centre	child	male	vaccine	1	0	0	0	skin_reaction_SJS	non_serious	not_assessed	34	0	0	0	recovered	25	2,023
29	emerging	PV_0200	nurse	pharmacy	elderly	female	antidiabetic	0	0	0	0	hepatotoxicity	non_serious	not_assessed	50	1	0	0	not_recovered	25	2,024
30	emerging	PV_0036	other	tertiary_hospital	adult	male	antimalarial	0	0	0	0	skin_reaction_SJS	non_serious	not_assessed	46	1	0	0	not_recovered	25	2,023
31	emerging	PV_0005	pharmacist	community	adult	female	anticonvulsant	1	0	0	0	GI_disturbance	serious_disability	not_assessed	44	0	0	0	not_recovered	25	2,024
32	emerging	PV_0026	pharmacist	health_centre	adult	male	anti_TB	0	0	0	0	GI_disturbance	non_serious	unclassifiable	48	0	0	1	recovered	25	2,024
33	emerging	PV_0158	other	private_clinic	adult	female	anticonvulsant	0	0	0	0	nephrotoxicity	serious_hospitalisation	not_assessed	27	0	0	0	recovered	25	2,024
34	emerging	PV_0190	patient	district_hospital	child	male	vaccine	1	0	0	0	teratogenicity	non_serious	not_assessed	59	0	0	0	unknown	25	2,020
35	emerging	PV_0017	physician	tertiary_hospital	adult	female	herbal_traditional	0	0	1	0	lactic_acidosis	serious_disability	possible	30	1	0	0	not_recovered	25	2,021
36	emerging	PV_0112	CHW	district_hospital	elderly	male	antihypertensive	1	0	0	0	skin_reaction_SJS	non_serious	not_assessed	17	0	0	0	recovering	25	2,021
37	emerging	PV_0036	other	private_clinic	adult	male	antifungal	1	1	0	0	hepatotoxicity	non_serious	possible	42	0	0	0	unknown	25	2,023
38	emerging	PV_0172	pharmacist	community	adolescent	male	herbal_traditional	1	0	0	0	hypoglycaemia	non_serious	possible	45	0	0	0	unknown	25	2,024
39	emerging	PV_0190	nurse	pharmacy	adult	female	vaccine	1	0	1	0	teratogenicity	non_serious	not_assessed	54	0	1	1	recovered	25	2,020
40	emerging	PV_0132	nurse	health_centre	adult	male	antimalarial	1	1	0	0	skin_reaction_SJS	non_serious	not_assessed	49	1	1	0	recovered	25	2,023
41	emerging	PV_0083	pharmacist	health_centre	adult	female	ARV	1	0	0	0	anaphylaxis	non_serious	not_assessed	22	0	0	1	recovered	25	2,021
42	emerging	PV_0147	other	tertiary_hospital	adolescent	male	antimalarial	1	0	0	0	ototoxicity	serious_disability	unlikely	66	1	0	0	recovered	25	2,024
43	emerging	PV_0167	patient	pharmacy	adult	female	vaccine	1	0	0	0	GI_disturbance	non_serious	possible	41	1	0	0	unknown	25	2,022
44	emerging	PV_0136	CHW	health_centre	child	male	antidiabetic	1	0	0	0	hepatotoxicity	non_serious	not_assessed	53	1	0	0	recovering	25	2,023
45	emerging	PV_0055	physician	health_centre	adult	female	antimalarial	1	0	0	0	QT_prolongation	non_serious	not_assessed	45	0	0	0	unknown	25	2,024
46	emerging	PV_0082	nurse	health_centre	neonate	female	anti_TB	1	0	0	0	hypoglycaemia	non_serious	not_assessed	32	1	0	0	recovered	25	2,023
47	emerging	PV_0264	CHW	health_centre	adult	female	vaccine	1	1	0	0	drug_interaction	serious_hospitalisation	probable	67	1	0	0	fatal	25	2,024
48	emerging	PV_0220	nurse	district_hospital	adult	female	antihypertensive	0	0	0	0	GI_disturbance	non_serious	probable	46	0	0	0	recovered	25	2,024
49	emerging	PV_0175	pharmacist	district_hospital	adolescent	female	antibiotic	1	0	0	0	hypoglycaemia	non_serious	probable	36	0	0	0	unknown	25	2,024
50	emerging	PV_0264	other	tertiary_hospital	child	male	NSAID_analgesic	1	0	0	0	neurotoxicity	non_serious	not_assessed	35	0	0	0	recovered	25	2,022
51	emerging	PV_0250	CHW	community	adolescent	female	herbal_traditional	1	0	0	0	skin_reaction_SJS	non_serious	not_assessed	30	0	0	0	recovered	25	2,023
52	emerging	PV_0122	pharmacist	district_hospital	child	female	vaccine	1	0	0	0	neurotoxicity	non_serious	probable	46	0	0	1	not_recovered	25	2,021
53	emerging	PV_0050	physician	tertiary_hospital	elderly	male	antihypertensive	1	0	0	0	skin_reaction_SJS	fatal	not_assessed	5	0	0	0	recovered	25	2,022
54	emerging	PV_0076	CHW	private_clinic	adult	female	antifungal	1	0	1	0	GI_disturbance	non_serious	not_assessed	40	1	0	0	unknown	25	2,022
55	emerging	PV_0124	nurse	private_clinic	adult	female	ARV	1	0	0	0	hepatotoxicity	non_serious	not_assessed	35	0	0	0	recovering	25	2,024
56	emerging	PV_0218	nurse	health_centre	adult	female	anti_TB	1	0	0	0	GI_disturbance	non_serious	possible	34	0	1	0	recovered	25	2,024
57	emerging	PV_0281	pharmacist	private_clinic	child	male	antibiotic	1	0	0	0	skin_reaction_SJS	non_serious	not_assessed	34	0	0	0	recovered	25	2,024
58	emerging	PV_0258	nurse	private_clinic	neonate	male	herbal_traditional	1	0	0	0	drug_interaction	non_serious	not_assessed	50	0	0	0	unknown	25	2,024
59	emerging	PV_0095	other	private_clinic	adult	female	anti_TB	1	0	0	0	QT_prolongation	non_serious	not_assessed	61	0	0	1	recovered	25	2,022
60	emerging	PV_0253	CHW	community	child	female	anti_TB	0	0	0	0	GI_disturbance	non_serious	not_assessed	61	1	1	0	recovered	25	2,024
61	emerging	PV_0067	physician	community	child	male	NSAID_analgesic	1	0	0	0	teratogenicity	fatal	not_assessed	63	0	0	0	recovering	25	2,020
62	emerging	PV_0199	patient	health_centre	adult	female	anti_TB	1	0	0	0	haematological_toxicity	serious_disability	unlikely	57	1	0	1	recovered	25	2,020
63	emerging	PV_0026	CHW	tertiary_hospital	adult	female	antibiotic	0	0	0	0	drug_interaction	non_serious	not_assessed	59	0	0	0	unknown	25	2,023
64	emerging	PV_0131	nurse	district_hospital	adolescent	female	antimalarial	1	0	0	0	GI_disturbance	fatal	possible	50	0	0	0	recovered	25	2,021
65	emerging	PV_0142	pharmacist	private_clinic	adult	female	antidiabetic	1	1	0	0	haematological_toxicity	non_serious	not_assessed	38	0	0	0	recovered	25	2,023
66	emerging	PV_0197	pharmacist	health_centre	adult	male	antimalarial	1	0	0	0	skin_reaction_SJS	serious_disability	not_assessed	55	0	1	0	not_recovered	25	2,021
67	emerging	PV_0091	pharmacist	tertiary_hospital	adolescent	male	antibiotic	1	0	0	0	GI_disturbance	non_serious	not_assessed	44	0	0	0	unknown	25	2,020
68	emerging	PV_0204	physician	tertiary_hospital	adult	male	herbal_traditional	0	0	0	0	teratogenicity	non_serious	not_assessed	50	0	0	0	recovered	25	2,024
69	emerging	PV_0098	nurse	pharmacy	adult	male	antihypertensive	1	0	0	0	nephrotoxicity	serious_disability	not_assessed	65	0	0	0	unknown	25	2,024
70	emerging	PV_0150	nurse	district_hospital	adult	female	antidiabetic	1	0	0	0	GI_disturbance	non_serious	unlikely	41	1	0	0	recovered	25	2,024
71	emerging	PV_0291	nurse	private_clinic	infant	female	antifungal	1	1	1	0	neurotoxicity	non_serious	not_assessed	7	0	0	1	unknown	25	2,022
72	emerging	PV_0278	CHW	health_centre	adult	male	antibiotic	0	0	0	0	teratogenicity	serious_life_threatening	not_assessed	22	0	0	0	recovered	25	2,024
73	emerging	PV_0152	nurse	pharmacy	adult	male	ARV	1	1	0	0	drug_interaction	non_serious	not_assessed	67	1	0	0	not_recovered	25	2,021
74	emerging	PV_0145	patient	health_centre	adult	male	anti_TB	1	0	1	0	GI_disturbance	non_serious	not_assessed	44	0	0	1	not_recovered	25	2,024
75	emerging	PV_0265	nurse	health_centre	infant	female	antifungal	1	0	0	0	teratogenicity	non_serious	not_assessed	20	1	1	0	recovered	25	2,023
76	emerging	PV_0190	other	health_centre	adult	male	antimalarial	0	0	0	0	GI_disturbance	serious_life_threatening	unlikely	54	0	0	0	unknown	25	2,021
77	emerging	PV_0276	nurse	health_centre	elderly	female	NSAID_analgesic	1	0	0	0	GI_disturbance	non_serious	unlikely	26	0	0	1	recovered	25	2,021
78	emerging	PV_0238	other	district_hospital	adult	female	antibiotic	1	0	1	0	neurotoxicity	serious_life_threatening	not_assessed	39	1	0	0	unknown	25	2,024
79	emerging	PV_0039	physician	district_hospital	adult	female	vaccine	1	0	0	0	hypoglycaemia	serious_hospitalisation	not_assessed	53	0	0	0	recovered	25	2,021
80	emerging	PV_0105	nurse	health_centre	adult	male	corticosteroid	1	0	0	0	hepatotoxicity	non_serious	possible	44	0	0	0	recovering	25	2,020
81	emerging	PV_0240	patient	community	adult	female	antihypertensive	1	0	0	0	teratogenicity	non_serious	not_assessed	54	0	0	0	recovered	25	2,024
82	emerging	PV_0246	physician	district_hospital	adult	female	ARV	1	0	0	0	skin_reaction_SJS	non_serious	not_assessed	41	0	0	1	recovering	25	2,023
83	emerging	PV_0240	pharmacist	district_hospital	child	female	antimalarial	1	0	0	0	drug_interaction	non_serious	not_assessed	30	0	0	0	recovering	25	2,021
84	emerging	PV_0045	CHW	district_hospital	adult	male	anti_TB	1	0	0	0	injection_site_reaction	serious_life_threatening	not_assessed	35	0	0	0	unknown	25	2,024
85	emerging	PV_0151	nurse	tertiary_hospital	neonate	female	anti_TB	1	0	0	0	nephrotoxicity	non_serious	not_assessed	14	0	0	0	recovered	25	2,022
86	emerging	PV_0237	pharmacist	private_clinic	elderly	male	NSAID_analgesic	1	0	0	0	hepatotoxicity	serious_life_threatening	not_assessed	19	0	0	1	unknown	25	2,022
87	emerging	PV_0276	physician	private_clinic	elderly	male	ARV	0	0	0	0	GI_disturbance	non_serious	not_assessed	45	0	0	0	recovered	25	2,023
88	emerging	PV_0274	other	tertiary_hospital	adolescent	female	antimalarial	1	0	0	0	skin_reaction_SJS	non_serious	not_assessed	19	0	0	0	unknown	25	2,022
89	emerging	PV_0196	other	district_hospital	adult	female	anti_TB	1	0	0	0	GI_disturbance	serious_hospitalisation	not_assessed	34	0	0	0	recovered	25	2,024
90	emerging	PV_0121	nurse	district_hospital	elderly	male	antimalarial	1	0	0	0	anaphylaxis	serious_life_threatening	not_assessed	5	1	1	0	recovered	25	2,023
91	emerging	PV_0161	physician	community	elderly	female	herbal_traditional	1	0	0	0	injection_site_reaction	non_serious	probable	40	0	0	0	unknown	25	2,024
92	emerging	PV_0228	pharmacist	private_clinic	adult	female	vaccine	0	0	0	0	teratogenicity	non_serious	not_assessed	66	0	1	0	unknown	25	2,022
93	emerging	PV_0155	nurse	pharmacy	elderly	male	vaccine	1	0	0	0	drug_interaction	non_serious	unlikely	31	0	1	0	unknown	25	2,020
94	emerging	PV_0236	nurse	pharmacy	infant	female	herbal_traditional	0	0	0	0	neurotoxicity	serious_hospitalisation	probable	43	0	0	0	unknown	25	2,023
95	emerging	PV_0031	nurse	private_clinic	adolescent	female	ARV	1	1	0	0	teratogenicity	serious_life_threatening	not_assessed	49	1	1	1	recovered	25	2,024
96	emerging	PV_0143	physician	tertiary_hospital	elderly	female	antihypertensive	0	0	0	0	injection_site_reaction	non_serious	not_assessed	19	1	0	0	recovered	25	2,021
97	emerging	PV_0240	pharmacist	private_clinic	elderly	male	anticonvulsant	1	0	0	0	teratogenicity	non_serious	not_assessed	56	0	0	0	not_recovered	25	2,021
98	emerging	PV_0252	patient	private_clinic	adult	male	anti_TB	1	1	0	0	GI_disturbance	serious_hospitalisation	unlikely	33	0	0	0	not_recovered	25	2,024
99	emerging	PV_0279	nurse	private_clinic	adult	male	NSAID_analgesic	1	0	0	0	haematological_toxicity	serious_life_threatening	not_assessed	44	1	1	1	recovering	25	2,024
100	emerging	PV_0148	patient	tertiary_hospital	adult	male	antifungal	1	0	0	0	tendon_rupture	non_serious	not_assessed	11	0	0	0	unknown	25	2,024

End of preview. Expand in Data Studio

Post-Market Surveillance & Pharmacovigilance Dataset

Abstract

This dataset provides 30,000 simulated pharmacovigilance reports (10,000 per scenario) across three PV capacity levels in sub-Saharan Africa. Each record represents one adverse drug reaction report with 30+ variables including adverse event type, seriousness, causality assessment, SF medicine suspicion, ICSR completeness, VigiBase entry, and patient outcomes. Three scenarios: functional PV centre (25% serious, 65% causality assessed), emerging PV (35% serious, 25% assessed), minimal PV (50% serious, 5% assessed).

This dataset is entirely simulated. It must not be used for clinical or pharmacovigilance decisions.

1. Introduction

Africa contributes <2% of global ICSR reports to VigiBase despite 17% of global population. Only 55% of African countries have functional PV centres. ADR under-reporting is estimated at 90-95% — only 5-10% of ADRs are captured. SF medicines drive a significant share of adverse events, particularly in settings with weak regulatory capacity.

2. Parameterization Evidence (v2.0)

Parameter	Value Used	Source	Year
Africa <2% of VigiBase reports	<2%	UMC/VigiBase	2023
55% of African countries have PV	55%	WHO	2023
Under-reporting 90-95%	90-95%	Lancet	2019
ADR reporting 0.1-50/million	0.1-50	WHO	2023

3. Validation

Validation Report

4. Usage

from datasets import load_dataset
dataset = load_dataset("electricsheepafrica/postmarket-surveillance-pharmacovigilance", "emerging_pv_system")
df = dataset["train"].to_pandas()
print(df.groupby('seriousness').size())

5. References

Uppsala Monitoring Centre. VigiBase global ADR database.
WHO (2023). Pharmacovigilance in Africa.
Lancet (2019). Under-reporting of ADRs in SSA.
USAID SIAPS/PQM+. PV system strengthening.

Citation

@dataset{esa_pv_2025,
  title   = {Post-Market Surveillance and Pharmacovigilance Dataset},
  author  = {{Electric Sheep Africa}},
  year    = {2025},
  publisher = {Hugging Face},
  url     = {https://huggingface.co/datasets/electricsheepafrica/postmarket-surveillance-pharmacovigilance}
}

License

CC-BY-4.0

Downloads last month: 34